Associations between glycated albumin or hemoglobin A1c and the presence of coronary artery disease

Journal of Cardiology

Volumn 65, Issue 6, 2015, Pages 487-493

  Norimatsu, Kenji ^a   Miura, Shin ichiro ^a   Suematsu, Yasunori ^a   Shiga, Yuhei ^a   Miyase, Yuiko ^a   Nakamura, Ayumi ^a   Yamada, Mayumi ^a   Matsunaga, Akira ^a   Saku, Keijiro ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronary artery disease; Coronary computed tomography angiography; Glycated albumin; Hemoglobin A1c

Indexed keywords

BIGUANIDE; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SULFONYLUREA; TRIACYLGLYCEROL; URIC ACID; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; GLYCOSYLATED SERUM ALBUMIN; SERUM ALBUMIN;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ANGINA PECTORIS; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRUG USE; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; PREDICTION; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SMOKING; SUDDEN DEATH; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; ADVERSE EFFECTS; BLOOD; COMPLICATION; MIDDLE AGED; ODDS RATIO; RISK FACTOR;

AGE FACTORS; AGED; BIOMARKERS; BODY MASS INDEX; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SERUM ALBUMIN; SEX FACTORS; SMOKING;

EID: 84929510556     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2014.07.006     Document Type: Article

References (24)

1. Nathan D.M., Kuenen J., Borg R., Zheng H., Schoenfeld D., Heine R.J., A1c-Derived Average Glucose Study Group Translating the A1C assay into estimated average glucose values. Diabetes Care 2008, 31:1473-1478.
2. Yoshiuchi K., Matsuhisa M., Katakami N., Nakatani Y., Sakamoto K., Matsuoka T., Umayahara Y., Kosugi K., Kaneto H., Yamasaki Y., Hori M. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. Endocr J 2008, 55:503-507.
3. DECODE Study Group, The European Diabetes Epidemiology Group Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001, 161:397-405.
4. Nakagami T., Qiao Q., Tuomilehto J., Balkau B., Tajima N., Hu G. Screen-detected diabetes, hypertension and hypercholesterolemia as predictors of cardiovascular mortality in five populations of Asian origin: the DECODA study. Eur J Cardiovasc Prev Rehabil 2006, 13:555-561.
5. Chiasson J.L., Josse R.G., Gomis R., Hanefeld M., Karasik A., Laakso M. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 2003, 290:486-494.
6. Monnier L., Mas E., Ginet C., Michel F., Villon L., Cristol J.P., Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006, 295:1681-1687.
7. Selvin E., Francis L.M., Ballantyne C.M., Hoogeveen R.C., Coresh J., Brancati F.L., Steffes M.W. Nontraditional markers of glycemia: associations with microvascular conditions. Diabetes Care 2011, 34:960-967.
8. Pu L.J., Lu L., Shen W.F., Zhang Q., Zhang R.Y., Zhang J.S., Hu J., Yang Z.K., Ding F.H., Chen Q.J., Shen J., Fang D.H., Lou S. Increased serum glycated albumin level is associated with the presence and severity of coronary artery disease in type 2 diabetic patients. Circ J 2007, 71:1067-1073.
9. Mitsutake R., Niimura H., Miura S., Zhang B., Iwata A., Nishikawa H., Kawamura A., Kumagai K., Shirai K., Matsunaga A., Saku K. Clinical significance of the coronary calcification score by multidetector row computed tomography for the evaluation of coronary stenosis in Japanese patients. Circ J 2006, 70:1122-1127.
10. Dodge J.T., Brown B.G., Bolson E.L., Dodge H.T. Intrathoracic spatial location of coronary segments on the normal human heart. Circulation 1988, 78:1167-1180.
11. The Japan Atherosclerosis Society Goals of dislipidemia management. J Atheroscler Thromb 2009, 16(Suppl.):15-25. [chapter 3].
12. Koga M., Matsumoto S., Saito H., Kasayama S. Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients. Endocr J 2006, 53:387-391.
13. Tahara Y., Shima K. Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 1995, 18:440-447.
14. Takahashi S., Uchino H., Shimizu T., Kanazawa A., Tamura Y., Sakai K., Watada H., Hirose T., Kawamori R., Tanaka Y. Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control. Endocr J 2007, 54:139-144.
15. Hashimoto K., Osugi T., Noguchi S., Morimoto Y., Wasada K., Imai S., Waguri M., Toyoda R., Fujita T., Kasayama S., Koga M. A1C but not serum glycated albumin is elevated because of iron deficiency in late pregnancy in diabetic women. Diabetes Care 2010, 33:509-511.
16. Sany D., Elshahawy Y., Anwar W. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence. Saudi J Kidney Dis Transpl 2013, 24:260-273.
17. Sakuma N., Omura M., Oda E., Saito T. Converse contributions of fasting and postprandial glucose to HbA1c and glycated albumin. Diabetol Int 2011, 2:162-171.
18. Suwa T., Ohta A., Matsui T., Koganei R., Kato H., Kawata T., Sada Y., Ishii S., Kondo A., Murakami K., Katabami T., Tanaka Y. Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM). Endocr J 2010, 57:135-140.
19. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein H.C., Miller M.E., Byington R.P., Goff D.C., Bigger J.T., Buse J.B., Cushman W.C., Genuth S., Ismail-Beigi F., Grimm R.H., Probstfield J.L., Simons-Morton D.G., Friedewald W.T. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358:2545-2559.
20. ADVANCE Collaborative Group, Patel A., MacMahon S., Chalmers J., Neal B., Billot L., Woodward M., Marre M., Cooper M., Glasziou P., Grobbee D., Hamet P., Harrap S., Heller S., Liu L., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008, 358:2560-2572.
21. Koga M., Murai J., Saito H., Kasayama S. Glycated albumin and glycated hemoglobin are influenced differently by endogenous insulin secretion in patients with type 2 diabetes. Diabetes Care 2010, 33:270-272.
22. Bando Y., Toya D., Ushiogi Y., Tanaka N., Okafuji K., Fujisawa M. The relationship of fasting plasma glucose values and other variables to 2-h postload plasma glucose in Japanese subjects. Diabetes Care 2001, 24:1156-1160.
23. Ropers D., Rixe J., Anders K., Küttner A., Baum U., Bautz W., Daniel W.G., Achenbach S. Usefulness of multidetector row computed tomography with 64-×0.6-mm collimation and 330-ms rotation for the noninvasive detection of significant coronary artery stenoses. Am J Cardiol 2006, 97:343-348.
24. Fine J.J., Hopkins C.B., Ruff N., Newton F.C. Comparison of accuracy of 64-slice cardiovascular computed tomography with coronary angiography in patients with suspected coronary artery disease. Am J Cardiol 2006, 97:173-174.